Single-Cell Genomics Consultant
I guide teams on single-cell and nuclei sample prep, application development, and QC advisory and analysis.
With 20+ years of experience and 20+ peer reviewed publications, I can help your team successfully navigate end-to-end single-cell workflows.
Three kinds of engagement. Most start with a short call to work out which one you actually need.
for biotech R&D teams
For teams whose starting material fights back — solid tissue, FFPE, frozen, or precious low-input samples that won't yield clean cells or nuclei.
For teams choosing between platforms, or who already have one on the bench and need a working assay built on it.
For teams with data in hand who need to know whether it's sound, and what it will take to make the result defensible.
for platform and tools companies
For platform companies and investors deciding whether a new technology is real, where it fits, and which applications are worth building first.
For platform companies who need a working scientist — not a sales engineer — in front of the labs whose adoption decides whether a technology lands.
for attorneys and legal teams
Data interpretation and lay translation.
Most engagements begin because a decision is stuck — which platform, whether the data is trustworthy, why the samples keep failing. I want to understand the decision before I look at the protocol.
I have run these platforms myself, on difficult samples, at scale. Recommendations come with the protocol detail needed to act on them, not a summary slide.
I have spent years training customers on instruments in their own labs. The goal is that your team can run it again after I am gone, without me.
I help research teams and platform companies turn difficult samples into single-cell data and collateral to grow their businesses.
I have spent twenty years on the technical side of genomics and oncology research. I trained in academic labs on transcription and epigenetics in model systems and human disease. At the National Cancer Institute I led a functional genomics core working on rare variants in cancer. At Levitas Bio, I led development of an automated sample preparation platform and built the methods behind single-cell and single-nuclei workflows helping to drive over 80% of company revenue.
I can help you:
Tell me what you are working on and where it is stuck. If I am not the right person, I will usually know who is.
Taking on advisory and project work